Seok-Goo Cho

Emailchosgcatholic.ackr

h-index

Research activity per year

Research interests

Development of Cancer Immunotherapy > EBV-CTL in EBV-associated Lymphoma
Adoptive Cell Therapy following Autologous & Allogeneic HSCT
Intentional Induction of Allogeneic Mixed chimerism for Solid Organ Transplantation
Combinatory Cell-Based Immune Modulation with Mesenchymal Stem Cells & Regulatory Cells
Integration of Molecular Imaging in Translational Research

Education

INSTITUTION AND LOCATION	DEGREE	YEAR(s)	FIELD OF STUDY
The Catholic University of Korea, College of Medicine, Seoul, Korea	M.D.	1988	Medicine
The Catholic Catholic Graduate School of Medicine, Seoul, Korea	M.S.	1992	Internal Medicine
	Ph.D.	1998	Internal Medicine/Hematology

Professional Experience

1988-1995	Received Medical Doctor License (No.35974), Ministry of Health, Korea
1988-1989	Internship and Resident in Kangnam St. Mary Hospital, The Catholic University of Korea College of Medicine
1989-1992	Residency in St. Mary Hospital, The Catholic University of Korea College of Medicine
1992	Received Board Certificate of Internal Medicine (No. 3531), Korea
1992-1995	Served in Korean Army as physician
1995-1996	Fellowship of Internal medicine in St. Mary Hospital, Catholic Blood and Marrow Transplantation Center
1997	Board certified in subspecialty of Hematology, (No 697117) Korea
2001-2003	A scholarship research fellow of a TBRF (Tokyo Biochemical Research Foundation) postdoctoral fellowship program, Department of Molecular therapy, The Institute of Medical Science, The University of Tokyo (IMUST), Japan
1996-2009	Instructor, Assistant Professor, Associate Professor, Department of Hematology, The Catholic University of Korea College of Medicine
2009-2017	Director, Cell Therapy Center, Seoul St. Mary’s Hospital
2013-2017	Director, Catholic Institute of Cell Therapy, The Catholic University of Korea Institute of Biomedical Industry
2014-present	Director, Institute of Translational Research and Molecular Imaging, The Catholic University of Korea
2019-2021	Director, Lymphoma and Cell Therapy Research Center, Yeouido St. Mary’s Hospital
2019-2021	Director, Lymphoma-Myeloma Center, Catholic Hematology Hospital
2019-2021	Director, Department of Internal Medicine, Seoul St. Mary’s Hospital
2019-present	Chief Executive Officer, LucasBio Co., Ltd.
2021-present	President/Director of Industry-Academic Cooperation Foundation
2021-present	Dean for Research Affairs, The Catholic University of Korea

External positions

President/Director of Industry-Academic Cooperation Foundation, The Catholic University of Korea

Dean for Research Affairs, The Catholic University of Korea

Chief Executive Officer, LucasBio Co., Ltd.

Director, Institute of Translational Research and Molecular Imaging

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics where Seok-Goo Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

A clinical study to evaluate the safety and efficacy of autologous COVID-19 antigen specific T cell treatment in prolonged SARS-CoV-2 infected patients
Cho, S.-G. (CoI)
1/02/23 → 31/12/24
Project: Research
An investigator’s initiated trial to evaluate the safety of cytokine-induced-killer cells during early transplant period of autologous hematopoietic stem cell transplant recipients
Cho, S.-G. (PI)
1/01/21 → 31/12/25
Project: Research
A multi-center, Open, randomized, Phase I/II clinical trial to evaluate the safety and efficacy of combined maintenance of rituximab and cytokine-induced killer cells in elderly high-risk DLBCL(Diffuse Large B-Cell Lymphoma) patients responding to the first R-CHOP treatment
Cho, S.-G. (PI)
1/01/21 → 31/12/25
Project: Research
A phase I study to evaluate the safety of four repeated infusions of bone marrow-derived mesenchymal stem cells for the treatment of steroid-refractory and progressive chronic graft-versus host disease
Cho, S.-G. (PI)
8/11/16 → 31/07/19
Project: Research
TLR5 agonist (KMRC011) for treatment of graft-versus-host disease and enhancement of graft-versus-tumor effect
Cho, S.-G. (PI)
1/11/16 → 31/12/17
Project: Research

292 Article
16 Letter
8 Review article
6 Comment/debate
More

Cytokine-Induced Killer Cell Therapy as a Postremission Strategy in High-Risk Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Prospective Investigator-Initiated Clinical Study
Min, G. J., Kim, N., Im, K. I., Lee, J., Kim, T., Kim, D. J. & Cho, S. G., 2026, (Accepted/In press) In: Transplantation and Cellular Therapy.
Research output: Contribution to journal › Article › peer-review

Open Access
Effectiveness and Safety of Autologous Virus-Specific T-Cell Therapy for Persistent COVID-19 in People With Immunocompromise: A Clinical Trial Study
Lee, R., Kim, N., Kim, W. B., Im, K. I., Nho, D., Cho, S. Y., Park, C., Beck, K. S., Lee, G. H., Lee, I., Cho, S. G. & Lee, D. G., 15 Dec 2026, In: Clinical Infectious Diseases. 81, 6, p. e510-e514
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Outcomes of tisagenlecleucel versus allogeneic hematopoietic stem cell transplantation in relapsed or refractory large B-cell lymphoma
Kim, T. Y., Min, K. I., Min, G. J., Jeon, Y., Yahng, S. A., Cho, S. G. & Eom, K. S., Apr 2026, In: Cytotherapy. 28, 4, 102028.
Research output: Contribution to journal › Article › peer-review
Predicting treatment-free remission after thrombopoietin receptor agonist therapy in immune thrombocytopenia: real-world outcomes from a Korean cohort
Yoon, J. H., Lee, S., Kwag, D., Min, G. J., Park, S. S., Park, S., Lee, S. E., Cho, B. S., Eom, K. S., Kim, Y. J., Kim, H. J., Min, C. K. & Cho, S. G., Mar 2026, In: Journal of Thrombosis and Haemostasis. 24, 3, p. 1130-1140 11 p.
Research output: Contribution to journal › Article › peer-review
Prognostic factors and outcomes of tisagenlecleucel in relapsed or refractory B-cell malignancies: a single-center real-world study
Lee, S. J., Min, G. J., Park, S. S., Jeon, Y., Yoo, J. W., Jekarl, D. W., Lee, J. W., Eom, K. S., Chung, N. G., Min, C. K., Cho, S. G., Kim, Y. & Yoon, J. H., Feb 2026, In: Cytotherapy. 28, 2, 102002.
Research output: Contribution to journal › Article › peer-review

Data from Catholic University of Korea Update Knowledge in Chronic Lymphocytic Leukemia (Inferior Outcomes of Fludarabine-Cyclophosphamide-Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia ...)
Kim, M. S., Yahng, S. A., Woo, Y. S., Eom, K. S., Cho, S.-G. & Min, G. J.
11/02/25
1 item of Media coverage
Press/Media
Research Study Findings from Catholic University Lymphoma Group Update Understanding of Follicular Lymphoma (The Role of Small Bowel Capsule Endoscopy in Determining the Treatment Strategy for Duodenal Follicular Lymphoma: A Single-Center ...)
Cho, Y. K., Woo, Y. S., Park, J. M., Choi, B. O., Cho, S.-G., O, J. H. & Min, G. J.
10/02/25
1 item of Media coverage
Press/Media
Studies from Catholic University of Korea Describe New Findings in Acute Myeloid Leukemia (Single-Cell RNA Sequencing Elucidates Cellular Origin and Heterogeneity in Acute Myeloid Leukemia)
Kim, Y. J., Lee, S., Lee, E. K., Eom, K. S., Park, S., Lee, S. E., Kim, H. J., Cho, S.-G. & Min, G. J.
25/12/24
1 item of Media coverage
Press/Media
Catholic University of Korea Researcher Discusses Research in Acute Lymphoblastic Leukemia (Real-World Experience of Blinatumomab for 8 Years Regarding Predictive Factors Including Lymphocyte Kinetics for Response and Survival Outcome in Adult ...)
Kim, Y. J., Lee, S., Lee, E. K., Eom, K. S., Park, S., Lee, S. E., Kim, H. J., Cho, B. S., Cho, S.-G. & Min, G. J.
20/12/24
1 item of Media coverage
Press/Media
Data on Chemotherapy Described by Researchers at Catholic University of Korea (DL-ICE as a bridge to allogeneic transplantation in relapsed/refractory PTCL: survival outcomes and prognostic factors)
Cho, S.-G., Jeon, Y. & Min, G. J.
20/12/24
1 item of Media coverage
Press/Media

Seok-Goo Cho

Personal profile

Research interests

Education

Professional Experience

External positions

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

A clinical study to evaluate the safety and efficacy of autologous COVID-19 antigen specific T cell treatment in prolonged SARS-CoV-2 infected patients

An investigator’s initiated trial to evaluate the safety of cytokine-induced-killer cells during early transplant period of autologous hematopoietic stem cell transplant recipients

A multi-center, Open, randomized, Phase I/II clinical trial to evaluate the safety and efficacy of combined maintenance of rituximab and cytokine-induced killer cells in elderly high-risk DLBCL(Diffuse Large B-Cell Lymphoma) patients responding to the first R-CHOP treatment

A phase I study to evaluate the safety of four repeated infusions of bone marrow-derived mesenchymal stem cells for the treatment of steroid-refractory and progressive chronic graft-versus host disease

TLR5 agonist (KMRC011) for treatment of graft-versus-host disease and enhancement of graft-versus-tumor effect

Cytokine-Induced Killer Cell Therapy as a Postremission Strategy in High-Risk Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Prospective Investigator-Initiated Clinical Study

Effectiveness and Safety of Autologous Virus-Specific T-Cell Therapy for Persistent COVID-19 in People With Immunocompromise: A Clinical Trial Study

Outcomes of tisagenlecleucel versus allogeneic hematopoietic stem cell transplantation in relapsed or refractory large B-cell lymphoma

Predicting treatment-free remission after thrombopoietin receptor agonist therapy in immune thrombocytopenia: real-world outcomes from a Korean cohort

Prognostic factors and outcomes of tisagenlecleucel in relapsed or refractory B-cell malignancies: a single-center real-world study

Data from Catholic University of Korea Update Knowledge in Chronic Lymphocytic Leukemia (Inferior Outcomes of Fludarabine-Cyclophosphamide-Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia ...)

Research Study Findings from Catholic University Lymphoma Group Update Understanding of Follicular Lymphoma (The Role of Small Bowel Capsule Endoscopy in Determining the Treatment Strategy for Duodenal Follicular Lymphoma: A Single-Center ...)

Studies from Catholic University of Korea Describe New Findings in Acute Myeloid Leukemia (Single-Cell RNA Sequencing Elucidates Cellular Origin and Heterogeneity in Acute Myeloid Leukemia)

Catholic University of Korea Researcher Discusses Research in Acute Lymphoblastic Leukemia (Real-World Experience of Blinatumomab for 8 Years Regarding Predictive Factors Including Lymphocyte Kinetics for Response and Survival Outcome in Adult ...)

Data on Chemotherapy Described by Researchers at Catholic University of Korea (DL-ICE as a bridge to allogeneic transplantation in relapsed/refractory PTCL: survival outcomes and prognostic factors)

Seok-Goo Cho

Personal profile

Research interests

Education

Professional Experience

External positions

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output

Press/Media